Key Financial Data Of Group

StemCell Institute - Filing #7253194

Concept 2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
Key financial data of group
Business results of group
Net sales
2,679,175,000 JPY
2,481,193,000 JPY
2,091,293,000 JPY
1,781,943,000 JPY
1,409,515,000 JPY
Ordinary profit (loss)
428,773,000 JPY
417,271,000 JPY
300,365,000 JPY
212,554,000 JPY
92,407,000 JPY
Net assets
2,627,849,000 JPY
2,692,615,000 JPY
2,298,588,000 JPY
2,103,983,000 JPY
1,322,209,000 JPY
Total assets
7,500,939,000 JPY
6,543,075,000 JPY
5,811,615,000 JPY
5,215,602,000 JPY
3,958,493,000 JPY
Net assets per share
258.35
262.78
224.33
205.33
135.83
Basic earnings (loss) per share
37.67
30.35
19.33
13.20
6.41
Diluted earnings per share
Equity-to-asset ratio
0.3503 xbrli:pure
0.4115 xbrli:pure
0.3955 xbrli:pure
0.4034 xbrli:pure
0.3340 xbrli:pure
Rate of return on equity
0.1450 xbrli:pure
0.1246 xbrli:pure
0.0900 xbrli:pure
0.0781 xbrli:pure
0.0483 xbrli:pure
Price-earnings ratio
36.0 xbrli:pure
65.2 xbrli:pure
130.1 xbrli:pure
152.1 xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
467,685,000 JPY
334,625,000 JPY
99,672,000 JPY
469,290,000 JPY
238,996,000 JPY
Net cash provided by (used in) investing activities
-259,084,000 JPY
-811,773,000 JPY
-285,100,000 JPY
404,170,000 JPY
-520,262,000 JPY
Net cash provided by (used in) financing activities
146,704,000 JPY
-1,333,000 JPY
-869,000 JPY
644,373,000 JPY
JPY
Cash and cash equivalents
3,200,846,000 JPY
2,845,540,000 JPY
3,324,021,000 JPY
3,510,318,000 JPY
1,992,484,000 JPY
Number of employees
117 xbrli:pure
98 xbrli:pure
92 xbrli:pure
82 xbrli:pure
79 xbrli:pure
Average number of temporary employees
110 xbrli:pure
93 xbrli:pure
76 xbrli:pure
79 xbrli:pure
78 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.